Acute myeloid leukemia (AML) is a heterogeneous group ... We used oligonucleotide-based DNA microarrays to study global gene expression in ten AML+8 patients with +8 as the sole chromosomal ...

A comprehensive data set to address whether gene-expression microarrays are capable of complementing current diagnostic algorithms (for the identification of different leukemia subtypes ...

A classic study distinguished 27 cases of acute lymphoblastic leukemia(ALL) from 11 cases of AML, based on their gene expression patterns, [22] as illustrated by Dr. W Kern [23] of the University ...

Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission ...

They classified acute myeloid leukemia cells by their resemblance to gene expression of stem cells at different life stages, discovering that the normal stem cell age most reflective of leukemia ...

This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.

A research team made a pivotal discovery in the field of cancer immunotherapy. The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed ...

By profiling gene expression in HSCs, we identified an RNA-binding protein called Musashi-2 that is required for normal hematopoietic stem cells and is overexpressed in patients with a worse clinical ...

Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a ...

Researchers from the University of Missouri School of Medicine found that a targeted gene therapy may make acute myeloid leukemia (AML) more sensitive to chemotherapy, while also protecting the ...

The basis of peptide vaccination is the observation that leukemia ... protein expression of PR-3. [39] Taken together, these DC vaccination studies demonstrated that DC vaccination in AML patients ...